High vascular endothelial growth factor gene expression predicts poor outcome in patients with non-luminal A breast cancer.

Sa-Nguanraksa, Doonyapat; Chuangsuwanich, Tuenjai; Pongpruttipan, Tawatchai; O-Charoenrat, Pornchai

Sa-Nguanraksa, Doonyapat; Chuangsuwanich, Tuenjai; Pongpruttipan, Tawatchai; O-Charoenrat, Pornchai.

Afiliação

Sa-Nguanraksa D; Division of Head, Neck and Breast Surgery, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Chuangsuwanich T; Department of Pathology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
Pongpruttipan T; Department of Pathology, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
O-Charoenrat P; Division of Head, Neck and Breast Surgery, Department of Surgery, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

Mol Clin Oncol ; 3(5): 1103-1108, 2015 Sep.

Article em En | MEDLINE | ID: mdl-26623059

Palavras-chave

angiogenesis; breast cancer; growth factor; hormone receptor; human epidermal growth factor receptor 2; vascular endothelial growth factor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Mol Clin Oncol Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google